Planet Labs PBC (NYSE:PL – Get Free Report) had its price target lifted by analysts at Wedbush from $30.00 to $40.00 in a report issued on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Wedbush’s price target points to a potential upside of 47.75% from the company’s previous close.
A number of other brokerages also recently commented on PL. Craig Hallum restated a “buy” rating and issued a $30.00 target price on shares of Planet Labs PBC in a research note on Tuesday, January 13th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Planet Labs PBC in a report on Thursday, December 11th. Citigroup increased their price objective on Planet Labs PBC from $19.00 to $30.00 and gave the stock a “buy” rating in a research note on Tuesday, January 13th. Deutsche Bank Aktiengesellschaft raised their price objective on Planet Labs PBC from $16.00 to $17.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Planet Labs PBC in a report on Thursday, January 22nd. Six investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $24.61.
View Our Latest Stock Analysis on PL
Planet Labs PBC Stock Up 9.1%
Planet Labs PBC (NYSE:PL – Get Free Report) last posted its quarterly earnings results on Thursday, March 19th. The company reported ($0.48) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.43). The company had revenue of $86.82 million during the quarter, compared to the consensus estimate of $78.17 million. Planet Labs PBC had a negative return on equity of 31.01% and a negative net margin of 45.87%.The business’s revenue was up 41.1% compared to the same quarter last year. Analysts anticipate that Planet Labs PBC will post -0.37 EPS for the current year.
Insider Buying and Selling at Planet Labs PBC
In related news, Director Vijaya Gadde sold 20,000 shares of Planet Labs PBC stock in a transaction that occurred on Thursday, January 22nd. The shares were sold at an average price of $26.77, for a total transaction of $535,400.00. Following the transaction, the director directly owned 250,169 shares of the company’s stock, valued at $6,697,024.13. This trade represents a 7.40% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Kristen Robinson sold 47,835 shares of the business’s stock in a transaction that occurred on Wednesday, January 21st. The stock was sold at an average price of $26.96, for a total transaction of $1,289,631.60. Following the completion of the transaction, the director directly owned 222,897 shares of the company’s stock, valued at $6,009,303.12. This trade represents a 17.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 292,348 shares of company stock valued at $7,323,958. 17.53% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Planet Labs PBC
A number of hedge funds have recently made changes to their positions in PL. Wellington Shields & Co. LLC boosted its position in Planet Labs PBC by 2.8% during the fourth quarter. Wellington Shields & Co. LLC now owns 15,776 shares of the company’s stock valued at $311,000 after purchasing an additional 435 shares in the last quarter. Xponance LLC raised its holdings in Planet Labs PBC by 3.1% in the fourth quarter. Xponance LLC now owns 18,656 shares of the company’s stock worth $368,000 after purchasing an additional 555 shares in the last quarter. Wealthfront Advisers LLC lifted its position in shares of Planet Labs PBC by 5.4% during the fourth quarter. Wealthfront Advisers LLC now owns 12,715 shares of the company’s stock valued at $251,000 after buying an additional 657 shares during the last quarter. Pictet Asset Management Holding SA lifted its position in shares of Planet Labs PBC by 2.1% during the fourth quarter. Pictet Asset Management Holding SA now owns 33,090 shares of the company’s stock valued at $653,000 after buying an additional 690 shares during the last quarter. Finally, Parkside Financial Bank & Trust boosted its holdings in shares of Planet Labs PBC by 92.5% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,550 shares of the company’s stock valued at $31,000 after buying an additional 745 shares in the last quarter. 41.71% of the stock is currently owned by hedge funds and other institutional investors.
Key Stories Impacting Planet Labs PBC
Here are the key news stories impacting Planet Labs PBC this week:
- Positive Sentiment: Revenue and guidance beats — Q4 revenue came in above estimates (≈$86.8M, +41% YoY) and management issued a FY2027 revenue midpoint implying ~39% growth, well above consensus; investors are rewarding the stronger top‑line outlook. Why is Planet Labs’ stock soaring?
- Positive Sentiment: AI and strategic partnerships — Planet highlighted AI integration opportunities (including Google R&D ties and in‑orbit AI discussions) as a demand multiplier for civil/commercial customers, supporting a re‑rating of growth expectations. Planet Labs’ stock soars as the satellite company says AI will unlock more business
- Positive Sentiment: Backlog and cash flow improvements — Management reported a materially larger backlog (~$900M, +77% YoY) and positive full‑year adjusted EBITDA and free cash flow for FY2026, lending credibility to durable revenue streams. Planet Reports Financial Results for Fourth Quarter and Full Fiscal Year 2026
- Neutral Sentiment: Operational progress — Fleet expansion (satellite launches, manufacturing capacity plans) and new deals were reiterated, supporting long‑term growth but requiring near‑term investment. Planet Reports Financial Results for Fourth Quarter and Full Fiscal Year 2026
- Neutral Sentiment: Mixed EPS / accounting signals — Different outlets noted varying EPS presentations (adjusted break‑even vs. some GAAP misses), so headline profitability depends on which metric investors focus on. Planet Labs PBC (PL) Reports Break-Even Earnings for Q4
- Negative Sentiment: Profitability pressure ahead — Management guided to a lower adjusted EBITDA range for FY2027 (flat to low single‑digit millions) as it scales to fulfill backlog, implying near‑term margin dilution and higher capex. Planet Reports Financial Results for Fourth Quarter and Full Fiscal Year 2026
- Negative Sentiment: High valuation risk — The rally has pushed valuation multiples to elevated levels, so the stock increasingly prices in flawless execution and sustained AI‑driven commercial adoption; any slowdown could trigger volatility. Planet Labs stock page
About Planet Labs PBC
Planet Labs PBC is a public benefit corporation that operates one of the largest fleets of Earth-imaging satellites, providing high-frequency, high-resolution imagery and data analytics to a broad range of industries. The company’s multi-spectral satellite constellation captures daily snapshots of the planet, enabling clients to monitor changes in agriculture, forestry, urban development, energy infrastructure and environmental conditions. Planet’s imagery platform is designed to support timely decision-making by transforming raw satellite data into actionable insights for business and government users.
Founded in 2010 by former NASA scientists Will Marshall, Robbie Schingler and Chris Boshuizen, Planet Labs grew from a small startup into a key provider in the satellite imaging sector.
Read More
Receive News & Ratings for Planet Labs PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Planet Labs PBC and related companies with MarketBeat.com's FREE daily email newsletter.
